Tender

Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis

NHS BLOOD & TRANSPLANT

This public procurement record has 1 release in its history.

Tender

10 Mar 2021 at 22:56

Summary of the contracting process

NHS Blood & Transplant is currently conducting an active procurement process titled "Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis". This procurement, classified under the medical consumables industry, seeks to supply consumables and maintenance for therapeutic apheresis services across multiple locations in England and South Wales. The open procedure tender is scheduled to close on 13th April 2021, with an intended award date in the same month, for a Framework Agreement lasting two years with potential one-year extensions. The procurement falls under the goods category and involves various NHS authorities who may purchase against this framework.

This tender presents substantial opportunities for businesses, particularly those operating in the healthcare sector, specialising in medical consumables, repair and maintenance of medical equipment, or therapeutic products. Companies that can supply consumables for apheresis machines or provide related services would be well-positioned to compete for this contract, ultimately allowing for growth within the NHS supply chain. Engaging in this process could lead to long-term business relationships with NHS authorities and contribute to the enhancement of health services provided to patients.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis

Notice Description

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection. The requirement of this procurement is for the supply of consumables and maintenance of the existing ART Universal machines. This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust.

Lot Information

Lot 1

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection. The requirement of this procurement is for the supply of consumables and maintenance of the existing ART Universal machines. This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trusts.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-029a88
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/004887-2021
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

50 - Repair and maintenance services


CPV Codes

33140000 - Medical consumables

33693000 - Other therapeutic products

50421000 - Repair and maintenance services of medical equipment

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
10 Mar 20214 years ago
Submission Deadline
13 Apr 2021Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD & TRANSPLANT
Contact Name
Not specified
Contact Email
marta.drozdzowska@nhsbt.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
FILTON, BRISTOL
Postcode
BS34 7QH
Post Town
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-029a88-2021-03-10T22:56:05Z",
    "date": "2021-03-10T22:56:05Z",
    "ocid": "ocds-h6vhtk-029a88",
    "initiationType": "tender",
    "tender": {
        "id": "NHSBT1498",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "33140000",
            "description": "Medical consumables"
        },
        "mainProcurementCategory": "goods",
        "description": "The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection. The requirement of this procurement is for the supply of consumables and maintenance of the existing ART Universal machines. This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust.",
        "lots": [
            {
                "id": "1",
                "description": "The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection. The requirement of this procurement is for the supply of consumables and maintenance of the existing ART Universal machines. This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trusts.",
                "contractPeriod": {
                    "durationInDays": 720
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": false,
                "status": "active"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33693000",
                        "description": "Other therapeutic products"
                    },
                    {
                        "scheme": "CPV",
                        "id": "50421000",
                        "description": "Repair and maintenance services of medical equipment"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "submissionMethod": [
            "electronicSubmission",
            "written"
        ],
        "submissionMethodDetails": "http://www.nhsbt.bravosolution.co.uk",
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ],
        "tenderPeriod": {
            "endDate": "2021-04-13T17:00:00+01:00"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ]
        },
        "awardPeriod": {
            "startDate": "2021-04-13T17:01:00+01:00"
        },
        "bidOpening": {
            "date": "2021-04-13T17:01:00+01:00"
        },
        "hasRecurrence": false
    },
    "parties": [
        {
            "id": "GB-FTS-1395",
            "name": "NHS Blood & Transplant",
            "identifier": {
                "legalName": "NHS Blood & Transplant"
            },
            "address": {
                "streetAddress": "North Bristol Park",
                "locality": "Filton, Bristol",
                "region": "UK",
                "postalCode": "BS34 7QH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "marta.drozdzowska@nhsbt.nhs.uk",
                "url": "http://www.nhsbt.bravosolution.co.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.nhsbt.nhs.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-6685",
            "name": "NHSBT",
            "identifier": {
                "legalName": "NHSBT"
            },
            "address": {
                "locality": "Bristol",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-1395",
        "name": "NHS Blood & Transplant"
    },
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:568414-2020:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}